This inventor holds 22 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent, primarily in Nucleic Acid Technologies. Top assignees: Somalogic, Incorporated, Ribozyme Pharmaceuticals, Incorporated, Crestone, Inc.. Active years: 1997-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
8 out of 75 
6 out of 110 
3 out of 7 
Years Active: 1997-2023
Areas of Expertise:
Title: Thale Jarvis: Innovating for a Healthier Tomorrow
Introduction
Thale Jarvis, based in Boulder, CO, is an accomplished inventor with a remarkable portfolio of 22 patents. His contributions to the fields of pharmaceuticals and diagnostics have made significant impacts on healthcare and treatment options. With a keen focus on developing novel compounds and methods, Jarvis continues to advance the boundaries of medical innovation.
Latest Patents
Among his latest patents, Jarvis has developed antimycobacterial heterocyclic amides, which present novel compounds exhibiting useful antimycobacterial activity. This invention also encompasses pharmaceutical compositions and methods for producing these compounds. Furthermore, he has worked on lung cancer biomarkers and their applications. This recent application includes a comprehensive range of biomarkers, methods, devices, reagents, systems, and kits for the detection and diagnosis of lung cancer. His innovations enable the diagnosis of lung cancer using specific biomarker values from biological samples, significantly improving the accuracy of detection and classification of pulmonary nodules.
Career Highlights
Throughout his career, Thale Jarvis has made strides while working with esteemed organizations such as Somalogic, Incorporated and Ribozyme Pharmaceuticals, Incorporated. His work within these companies showcases his dedication to advancing scientific research and innovation.
Collaborations
Jarvis has collaborated with notable colleagues in his field, including Nebojsa Janjic and James A. McSwiggen. These partnerships exemplify the collaborative spirit necessary for driving innovation and enhancing the development of essential health technologies.
Conclusion
Thale Jarvis' extensive patent portfolio and collaborative efforts underline his pivotal role as an inventor and innovator. His dedication to developing advanced diagnostic methods and therapeutic compounds continues to contribute positively to the medical field, promising a healthier future for individuals affected by diseases such as lung cancer. As he moves forward, his ongoing contributions will undoubtedly further the impact of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile